Zimmer has announced its 2010 2nd quarter financial results.  According to the report, Zimmer is announcing net sales of $1.06 billion, an increase of 3.7% over the prior year period.  These numbers represent steady and expected business for the company, yet, the bottom line has decreased 21 percent during this quarter as the company set aside an additional $75 [...]

Zimmer Inc. is now offering a new metal-on-metal hip replacement device called the Zimmer MMC Cup.  This cup is designed to be sold with the Metasul® LDH ® Large Diameter Heads.  On Zimmer’s website, this implant is advertised as the new hip option for younger patients.  It is also marketed towards surgeons as a well [...]

Barry Meier has written yet another enlightening article about the state of today’s medical device manufacturing.  In his latest article, published in the New York Times on April 2, 2010, Mr. Meier explains that medical device manufacturers are not required , and only very rarely do, offer warranties on their hip and knee joint devices.  [...]

In an article published by the New York Times on March 3, 2010, theories are discussed about what is causing the Zimmer Durom to fail at such an unacceptable rate.  The article, As Use of Metal-on-Metal Hip Implants Grows, Studies Raise Concerns, written by Barry Meier, who has written two previous articles discussing the Durom, [...]

In the case that Zimmer’s shareholders filed against Zimmer Holdings, Inc. and Zimmer’s two top officials, CEO David Dvorak and CFO James Crines, an amended consolidated complaint, recently filed, elaborates on the evidence against Zimmer’s top officials that demonstrates the information they concealed.   The evidence includes over 20 confidential witnesses, ranging from employees over Zimmer to sales [...]

Under the Freedom of Information Act, the Maglio Christopher Toale & Pitts Law Firm was able to obtain communications between Zimmer, Inc. and the Food and Drug Administration.  Included in this information was Zimmer’s Correction and Removal Report to the FDA, including letters sent to the surgeons implanting the Durom, information on the devices, Medical Device [...]

Zimmer shareholders filed a securities class action last year against Zimmer Holdings, Inc. and two of it’s top officers, claiming that the defendents withheld information about production issues at one of their manufacturing plants and the failures occuring with the Durom cup.  According to the complaint, Zimmer had made statements to the shareholders projecting a [...]

In August of last year, Zimmer, Inc. took the Zimmer Durom cup off the market for a week in order to update their surgical technique handbook and retrain surgeons who to implant the Durom properly.  Zimmer claimed that it had been surgical technique that lead to widespread failures of the cup.  We have reviewed the [...]

Zimmer Holdings, Inc. recently released their third quarter earnings for 2009.  They advertised a total revenue of $966 million for that quarter, a 3.6% improvement from last year’s third quarter.  Interestingly, they have disclosed how much money they are setting aside to cover the settlement of Durom failure claims.  In the release, Zimmer writes this [...]

The Journal Gazette of Fort Wayne, Indiana, ran a story this week chronicling the past year since the massive failure of the Zimmer Durom cup became widely known.  In the article titled, “Zimmer’s Hip Takes a Hit”, reporter Michael Schroeder starts by highlighting the story of Durom patient Trudie Millerburg, who lost two years of her life [...]